Medpace Holdings, Inc. 8-K

What Happened

• Medpace Holdings, Inc. filed an 8-K on April 22, 2026 announcing its quarterly financial results for the three months ended March 31, 2026. The company posted a press release with the full results on its website (furnished as Exhibit 99.1).
• Separately, on April 21, 2026, President Jesse Geiger notified the company he will retire and resign as President effective May 31, 2026. The company states this is not due to any disagreement with Medpace’s operations, policies, or practices. CEO August Troendle will reassume the role of President on Mr. Geiger’s resignation date and serve until a successor is appointed.

Key Details

• Filing date: April 22, 2026 (Form 8-K, Item 2.02 and Item 5.02).
• Quarterly results announced cover the period ended March 31, 2026; press release provided as Exhibit 99.1 on the company website.
• Executive change: Jesse Geiger to retire and resign as President effective May 31, 2026; August Troendle (CEO) will act as President thereafter.
• The 8-K was signed by Kevin M. Brady, Chief Financial Officer.

Why It Matters

• Earnings and quarterly results: Investors should review the posted press release (Exhibit 99.1) for revenue, earnings, and any guidance changes that could affect valuation or near-term stock performance.
• Leadership continuity: The planned retirement and the CEO temporarily reassuming the President role indicate an orderly transition and reduce immediate governance risk. The company has not announced a successor timeline.
• No disagreement: The filing explicitly states the departure is not due to any dispute with the company, which is a positive governance signal for investors monitoring management stability.